ADT-1004: a first-in-class, oral pan-RAS inhibitor with robust antitumor activity in preclinical models of pancreatic ductal adenocarcinoma

IL-6 underlies microenvironment immunosuppression and resistance to therapy in glioblastoma

Conserved spatial subtypes and cellular neighborhoods of cancer-associated fibroblasts revealed by single-cell spatial multi-omics

Pilot clinical trial of neoadjuvant toll-like receptor 7 agonist (Imiquimod) immunotherapy in early-stage oral squamous cell carcinoma

Altered inflammatory mucosal signatures within their spatial and cellular context during active ileal Crohn’s disease

Multiomic mapping of the brain: same-section, fully-automated spatial RNA and protein detection on mouse frozen tissues

Multiomic mapping of the brain: same-section, fully-automated spatial RNA and protein detection on mouse frozen tissues

Understanding the Role of the Immune Contexture in Invasion and Metastasis of Solid Tumors Using Multiplexed Immunofluorescence and Image Analysis

Understanding the Role of the Immune Contexture in Invasion and Metastasis of Solid Tumors Using Multiplexed Immunofluorescence and Image Analysis

Progressive plasticity during colorectal cancer metastasis

ADT-1004: A First-in-Class, Orally Bioavailable Selective pan-RAS Inhibitor for 1 Pancreatic Ductal Adenocarcinoma

Acute kidney injury results in long-term alterations of kidney lymphatics in mice